PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 123 filers reported holding PULMONX CORP in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $18,485 | +17.3% | 1,410 | 0.0% | 0.00% | – |
| Q1 2023 | $15,764 | -94.3% | 1,410 | -95.7% | 0.00% | -100.0% |
| Q4 2022 | $275,349 | -48.6% | 32,663 | +1.4% | 0.00% | -33.3% |
| Q3 2022 | $536,000 | -71.4% | 32,201 | -74.7% | 0.00% | -72.7% |
| Q2 2022 | $1,874,000 | +924.0% | 127,331 | +1630.5% | 0.01% | +450.0% |
| Q1 2022 | $183,000 | -82.1% | 7,358 | -77.0% | 0.00% | -80.0% |
| Q4 2021 | $1,025,000 | +16.9% | 31,955 | +31.0% | 0.01% | -9.1% |
| Q3 2021 | $877,000 | +81.2% | 24,384 | +122.1% | 0.01% | +120.0% |
| Q2 2021 | $484,000 | +796.3% | 10,980 | +1313.1% | 0.01% | +400.0% |
| Q4 2020 | $54,000 | – | 777 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |